Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
The UK biotech, a former star of the London initial public offering (IPO) scene, said the strategic collaboration will help return genomic results of bacterial and fungal pathogens within hours, compared to days experienced with currently available technology. Shares in London-listed Nanopore opened 6% higher at market open on 10 April compared to market open on 9 April, the day the announcement was made. Nanopore and US-based Cepheid have already completed a proof-of-concept study that saw the two companies' technologies combined for infectious disease analysis. The new research uses only workflow now sees Cepheid's cartridge-based GeneXpert system used Oxford Nanopore's sequencing platform. Nanopore was spun out of Oxford University in 2005 with pioneering technology for sequencing nucleic acids on handheld devices. All the company's sequencing devices work by analysing long DNA or RNA fragments by monitoring an electrical current as the nucleic acids are passed through a pro
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher (NYSE:DHR) had its price target raised by analysts at Jefferies Financial Group Inc. from $245.00 to $255.00. They now have a "buy" rating on the stock.MarketBeat
- Danaher Schedules Fourth Quarter 2025 Earnings Conference CallPR Newswire
- Indicor Announces Leadership Transition [Yahoo! Finance]Yahoo! Finance
- Danaher (NYSE:DHR) was given a new $240.00 price target on by analysts at Wells Fargo & Company.MarketBeat
- NW Natural Holdings General Counsel Announces Retirement [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/21/25 - Beat
DHR
Sec Filings
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- 11/25/25 - Form 144
- DHR's page on the SEC website